Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Far in the lead is Lilly with its late-stage orforglipron, which in a June 2023 Phase II readout achieved weight loss between 9.4% and 14.7% at 36 weeks
Bring your repeat prescription list or GP summary letter to your appointment
Overview GLP-1 receptor agonist analog for research in metabolic regulation and appetite control
Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates
US$ 28.55
US$ 20.63
US$ 24.10
US$ 29.93
US$ 29.13
US$ 29.39
US$ 26.60
US$ 26.50
US$ 20.15
